|
ZBTB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.68898228736225E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.83617615240928E-12 |
| Normal-vs-Stage2 |
6.36370000028919E-07 |
| Normal-vs-Stage3 |
3.99390520655629E-11 |
| Normal-vs-Stage4 |
1.43499656601875E-11 |
| Stage1-vs-Stage2 |
8.531600E-01 |
| Stage1-vs-Stage3 |
1.145230E-01 |
| Stage1-vs-Stage4 |
3.404500E-02 |
| Stage2-vs-Stage3 |
3.999000E-01 |
| Stage2-vs-Stage4 |
1.388590E-01 |
| Stage3-vs-Stage4 |
4.040000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.88498130835069E-14 |
| Normal-vs-AfricanAmerican |
1.261950E-03 |
| Normal-vs-Asian |
8.05090000222108E-08 |
| Caucasian-vs-AfricanAmerican |
2.382000E-01 |
| Caucasian-vs-Asian |
7.374000E-01 |
| AfricanAmerican-vs-Asian |
4.789000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.56485976691101E-12 |
| Normal-vs-Female |
2.87281309852006E-12 |
| Male-vs-Female |
6.593200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.00040025947146E-11 |
| Normal-vs-Age(41-60Yrs) |
3.10673708980858E-12 |
| Normal-vs-Age(61-80Yrs) |
7.24019999509551E-09 |
| Normal-vs-Age(81-100Yrs) |
1.800220E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.387200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.816800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.591200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.787200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.652600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.092000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.524120E-02 |
| Classical-VS-Follicular |
1.988950E-01 |
| Classical-VS-Other |
5.668600E-01 |
| Classical-VS-Normal |
3.50780515745441E-11 |
| Tall-VS-Follicular |
1.175590E-01 |
| Tall-VS-Other |
4.825800E-01 |
| Tall-VS-Normal |
1.84700033045715E-10 |
| Follicular-VS-Other |
9.055400E-01 |
| Follicular-VS-Normal |
4.13870004933869E-09 |
| Other-VS-Normal |
5.023800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.05400022043511E-10 |
| Normal-vs-N1 |
1.91179960751242E-10 |
| N0-vs-N1 |
2.310800E-01 |
|
|
